Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Promising new drug treatment for traumatic brain injury

By Stark & Stark on August 2, 2004
Email this postTweet this postLike this postShare this post on LinkedIn

Forbes Magazine has published an article entitled, After the Accident which goes into great detail about a promising new treatment for people who suffer a traumatic brain injury. A new drug named dexanabinol is being developed by an Iselin, New Jersey firm named Pharmos. In studies which have been completed, the drug, if administered within the first six hours of injury, has been shown to assist in minimizing the damage caused by a traumatic brain injury. Dexanabinol has been shown to prevent swelling of the brain, act as an antioxidant and block damage by neurotransmitters which are released following an injury. I encourage you to follow the link above to read this encouraging article.

What I also found interesting about this article was some of the numbers which were presented. It was a sobering assessment of how pervasive traumatic brain injuries are in our society. I have excerpted these numbers in order to share them with you:

5.3 million Americans suffer from a traumatic brain injury related disability

1.5 million new traumatic brain injury incidents occur yearly

85,000 of these individuals are left with a lifelong disability

20:1 is the ratio of traumatic brain injury cases to spinal cord injury cases

Accidents that damage the brain kill 50,000 Americans a year

9 out of 10 marriages end in divorce when one partner has suffered brain damage from an accident

  • Posted in:
    Personal Injury
  • Blog:
    Traumatic Brain Injury Law Blog
  • Organization:
    Stark & Stark

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo